Cargando…
Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial
BACKGROUND: The increasing prevalence of type 2 diabetes poses a major public health challenge. Population-based screening and early treatment for type 2 diabetes could reduce this growing burden. However, uncertainty persists around the benefits of screening for type 2 diabetes. We assessed the eff...
Autores principales: | Simmons, Rebecca K, Echouffo-Tcheugui, Justin B, Sharp, Stephen J, Sargeant, Lincoln A, Williams, Kate M, Prevost, A Toby, Kinmonth, Ann Louise, Wareham, Nicholas J, Griffin, Simon J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lancet Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607818/ https://www.ncbi.nlm.nih.gov/pubmed/23040422 http://dx.doi.org/10.1016/S0140-6736(12)61422-6 |
Ejemplares similares
-
The ADDITION-Cambridge trial protocol: a cluster – randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients
por: Echouffo-Tcheugui, Justin B, et al.
Publicado: (2009) -
Changes in physical activity and modelled cardiovascular risk following diagnosis of diabetes: 1-year results from the ADDITION-Cambridge trial cohort
por: Barakat, A, et al.
Publicado: (2013) -
Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial
por: Paddison, Charlotte A M, et al.
Publicado: (2009) -
Changes in diet, cardiovascular risk factors and modelled cardiovascular risk following diagnosis of diabetes: 1-year results from the ADDITION-Cambridge trial cohort
por: Savory, L A, et al.
Publicado: (2014) -
Multiple behaviour change intervention and outcomes in recently diagnosed type 2 diabetes: the ADDITION-Plus randomised controlled trial
por: Griffin, Simon J., et al.
Publicado: (2014)